Researchers in the Department of Medical Social Sciences at Northwestern University, in a study paid for by AVEO Pharmaceuticals, are seeking individuals to participate in an online study of treatment side effects. Participants must be at least 18 years old and have previously been diagnosed with kidney cancer. Study participants do not need to be currently receiving treatment. Participants will receive a $50.00 gift card for participating in the study. More information about the study and links to enroll can be found here.
Which of these three criteria do you meet?
If you are currently receiving at least one of the following drugs: pazopanib (Votrient), sorafenib (Nexavar), sunitinib (Sutent), bevacizumab (Avastin), everolimus (Afinitor), temsirolimus (Torisel), tivozanib, or axitinib, please click or copy and paste this URL into your browser: https://www.assessmentcenter.net/ac1/Assessments/ValidationStudy1
If you are currently receiving treatment for kidney cancer, but you are not receiving any of the drugs listed in option a, please copy and paste this URL into your browser: https://www.assessmentcenter.net/ac1/Assessments/ValidationStudy2
If you are not receiving treatment for kidney cancer at this time, please click or copy and paste this URL into your browser: https://www.assessmentcenter.net/ac1/Assessments/ValidationStudy3